<DOC>
	<DOCNO>NCT02616861</DOCNO>
	<brief_summary>Stage 1 : To assess safety , tolerability , pharmacokinetic ( PK ) profile , pharmacodynamic ( PD ) effect IW-1973 Tablet administer orally healthy volunteer , feed fasted state , single-dose crossover study . Stage 2 : To assess safety , tolerability , PK profile , PD effect range dose IW-1973 Tablet administer orally healthy subject 21-day , multiple ascending-dose study optional up-titration dose level within cohort .</brief_summary>
	<brief_title>Trial IW-1973 ( A Stimulator Soluble Guanylate Cyclase ( sGC ) ) Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Subject ambulatory male female 18 55 year old Screening Visit Subject 's body mass index score &gt; 18.5 &lt; 30.0 kg/m2 Screening Visit Women childbearing potential must negative pregnancy test must agree use doublebarrier contraception Subject good health clinically significant finding physical examination Other inclusion criterion per protocol History clinically significant medical condition Other exclusion criterion per protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>